Consolidated Portfolio Review Corp Pfizer Inc Transaction History

Consolidated Portfolio Review Corp

  • $429 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 29, 2024
SELL
$26.13 - $33.94 $59,132 - $76,806
-2,263 Reduced 17.1%
10,970 $316 Million
Q3 2023

Nov 13, 2023
SELL
$32.09 - $37.51 $14,344 - $16,766
-447 Reduced 3.27%
13,233 $439 Million
Q2 2023

Aug 14, 2023
BUY
$36.12 - $41.79 $20,660 - $23,903
572 Added 4.36%
13,680 $502 Million
Q1 2023

May 11, 2023
BUY
$39.39 - $51.28 $516,324 - $672,178
13,108 New
13,108 $535 Million

Others Institutions Holding PFE

# of Institutions
3,219
Shares Held
3.71B
Call Options Held
73.2M
Put Options Held
108M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $165B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Consolidated Portfolio Review Corp Portfolio

Follow Consolidated Portfolio Review Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consolidated Portfolio Review Corp, based on Form 13F filings with the SEC.

News

Stay updated on Consolidated Portfolio Review Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email